LNAILunai Bioworks Inc.
$3.09
$0.11
(3.44%)
Closed $3.09
$0.01
(0.32%)
After Hours
EarningsSep 28
Mkt Cap$14.51M
Vol44,141.00
LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS
LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS PR Newswire SACRAMENTO, Calif., June 17, 2026 SACRAMENTO, Calif., June 17, 2026 /PRNewswire/ -- Fellow Shareholders,Over the past several months, Lunai Bioworks (NASDAQ: LNAI) has continued to execute its strategy...
PR Newswire
Lunai Bioworks (LNAI) Stock Is Trending Overnight Here's Why It Spiked Nearly 81% In After-Hours Session
Lunai Bioworks Inc. shares soared 80.88% after-hours after regaining Nasdaq compliance with minimum bid price requirements.read more...
Benzinga
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration PR Newswire SACRAMENTO, Calif. and SAN DIEGO, May...
PR Newswire
Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock
Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock PR Newswire WASHINGTON, May 22, 2026 WASHINGTON, May 22, 2026...
PR Newswire
LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT
LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT PR Newswire SACRAMENTO, Calif., May 20, 2026 SACRAMENTO, Calif., May 20, 2026 /PRNewswire/ --Lunai Bioworks, Inc. (Nasdaq: LNAI) (the "Company") today announced that it will effect a reverse stock...
PR Newswire
Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP
Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and...
PR Newswire
Stock Market Today: Dow Jones, S&P 500 Futures Edge Lower Amid Extension Of Israel-Lebanon Ceasefire Intel, SAP, Lunai Bioworks In Focus
U.S. stock futures were mixed on Friday following Thursday's decline, after President Donald Trump announced the extension of the ceasefire between Israel and Lebanon by three weeks. On Thursday, the...
Benzinga
Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships
Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient...
PR Newswire
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under...
PR Newswire
<
1
2
...
>